Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-25-000028
Filing Date
2025-01-06
Accepted
2025-01-06 19:30:11
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736209802.html 4  
1 FORM 4 wk-form4_1736209802.xml 4 4063
  Complete submission text file 0001599298-25-000028.txt   5665
Mailing Address 209 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address
Huber Jeff (Reporting) CIK: 0001463740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 25513047

Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)